Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

New cytokine-targeted therapies show promise for treating alopecia areata.

Activating TRPA1 reduces scarring and promotes tissue regeneration.

Certain gene variations may increase the risk and severity of alopecia areata.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

The study found no link between vitamin D deficiency and psoriasis but suggests more research is needed.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Mechanical surface cues can control macrophage behavior for better immunotherapy and tissue healing.

Upadacitinib effectively treats psoriasis and lichen planus together.

Restoring skin bacteria may help reduce hair loss.

Upadacitinib improved multiple immune-related conditions in one patient.

Combining fire needle therapy with doxycycline improves severe acne more than doxycycline alone.

Peptides improve skin health and treatments for hair loss and pregnancy-related skin issues are evolving.

Nanomedicines could offer better, longer-lasting psoriasis treatments with fewer side effects.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

New treatments offer hope for better managing hidradenitis suppurativa.

Innate lymphoid cells help us understand and manage allergic diseases better.